Wedgewood Launches Compounded Molnupiravir for the Treatment of Feline Infectious Peritonitis (FIP)
Autor: | Wedgewood |
---|---|
Zdroj: | Business Wire (English). 09/18/2024. |
Abstrakt: | Today, Wedgewood announces the addition of molnupiravir to its formulary. Originally developed for human viral infections, including COVID-19, molnupiravir has emerged as a promising option for both first- and second-line therapy of Feline Infectious Peritonitis (FIP). This often-fatal disease affects an estimated 15,000 US cats each year, posing a significant concern for veterinarians and cat owners alike. [ABSTRACT FROM PUBLISHER] |
Databáze: | Regional Business News |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |